The serotype distribution among healthy carriers before vaccination is essential for predicting the impact of pneumococcal conjugate vaccine on invasive disease
Stefan Flasche, Olivier Le Polain de Waroux, Katherine L. O’Brien, W. John Edmunds
Dive into the research topics of 'The serotype distribution among healthy carriers before vaccination is essential for predicting the impact of pneumococcal conjugate vaccine on invasive disease'. Together they form a unique fingerprint.